These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2032313)

  • 1. Clinical applications and standardization of apolipoprotein measurements in the diagnostic workup of lipid disorders.
    Cooper GR; Henderson LO; Smith SJ; Hannon WH
    Clin Chem; 1991 May; 37(5):619-20. PubMed ID: 2032313
    [No Abstract]   [Full Text] [Related]  

  • 2. Standardization of immunoassays for the quantitation of plasma Apo B protein.
    Rosseneu M; Vinaimont N; Vercaemst R; Dekeersgieter W; Belpaire F
    Anal Biochem; 1981 Sep; 116(1):204-10. PubMed ID: 7304980
    [No Abstract]   [Full Text] [Related]  

  • 3. Simplified immunonephelometric quantitation of apolipoprotein B in hyperlipoproteinemic serum.
    Heuck CC; Schlierf G
    Clin Chem; 1979 May; 25(5):782-5. PubMed ID: 219966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunonephelometric assay of human apolipoprotein AI.
    Lopes-Virella MF; Virella G; Evans G; Malenkos SB; Colwell JA
    Clin Chem; 1980 Jul; 26(8):1205-8. PubMed ID: 6771058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical value of apolipoprotein measurement.
    Bhatnagar D; Durrington PN
    Ann Clin Biochem; 1991 Sep; 28 ( Pt 5)():427-37. PubMed ID: 1958043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunonephelometry of apolipoprotein A-II in plasma.
    Rosseneu M; Vinaimont N; Musliner TA; Bernier D; Herbert PN; Belpaire F
    Clin Chem; 1984 Feb; 30(2):234-7. PubMed ID: 6420089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and management of lipid disorders in diabetic patients. A commentary for clinicians.
    Garber AJ; Vinik AI; Crespin SR
    Diabetes Care; 1992 Aug; 15(8):1068-74. PubMed ID: 1303635
    [No Abstract]   [Full Text] [Related]  

  • 8. Measurement of low apolipoprotein concentrations by optimized immunoturbidimetric applications.
    Porsch-Ozçürümez M; Westphal S; Luley C
    Clin Chem; 2001 Mar; 47(3):594-7. PubMed ID: 11238320
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of plasma triglyceride concentrations on the accuracy of immunoturbidimetric assays of apolipoprotein B.
    Walmsley TA; Grant S; George PM
    Clin Chem; 1991 May; 37(5):748-53. PubMed ID: 2032330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some considerations of methodology and standardization of apolipoprotein B immunoassays.
    Rosseneu M; Vercaemst R; Steinberg KK; Cooper GR
    Clin Chem; 1983 Mar; 29(3):427-33. PubMed ID: 6186412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of serum Apo A1 and Apo B: comparison of immunoturbidimetric and rate nephelometric techniques.
    Glueck CJ; McCray C; Speirs J
    Clin Chim Acta; 1991 Mar; 197(2):123-31. PubMed ID: 1904802
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitative determination of human plasma apolipoprotein A-I by laser immunonephelometry.
    Rosseneu M; Vercaemst R; Vinaimont N; Van Tornout P; Henderson LO; Herbert PN
    Clin Chem; 1981 Jun; 27(6):856-9. PubMed ID: 6786798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some considerations of methodology and standardization of apolipoprotein A-I immunoassays.
    Steinberg KK; Cooper GR; Graiser SR; Rosseneu M
    Clin Chem; 1983 Mar; 29(3):415-26. PubMed ID: 6402322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of serum apolipoproteins A1 and B by immunoturbidimetry using the Cobas-Bio centrifugal analyzer. Influence of hyperlipemia].
    Hachem H; Raynal G; Favre G; Hamza M; Canal P; Soula G
    Ann Biol Clin (Paris); 1985; 43(6):885-90. PubMed ID: 3938627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of apolipoprotein A-I by kinetic nephelometry.
    Weinstock N; Bartholome M; Seidel D
    Biochim Biophys Acta; 1981 Jan; 663(1):279-88. PubMed ID: 6783109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examination of a competitive enzyme-linked immunoassay (CELIA) technique and a laser nephelometric immunoassay technique for the measurement of apolipoprotein B.
    Vander Heiden GL; Sasse EA; Yorde DE; Madiedo G; Barboriak JJ
    Clin Chim Acta; 1983 Dec; 135(2):209-18. PubMed ID: 6360430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent advances in apolipoprotein measurement].
    Kubo N; Watano T; Sakurabayashi I
    Nihon Rinsho; 1994 Dec; 52(12):3139-45. PubMed ID: 7853702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Low and very low density lipoproteins. Turbidimetric estimation and clinical applications].
    Fruchart JC; bu Tsumbu B; Dewailly P; Jaillard J; Sezille G
    Nouv Presse Med; 1976 Jun; 5(26):1641-2. PubMed ID: 181728
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunoturbidimetric techniques for quantifying apolipoproteins CII and CIII.
    Rifai N; Silverman LM
    Clin Chem; 1986 Oct; 32(10):1969-72. PubMed ID: 3093121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current methods for apolipoprotein evaluation in normal and dyslipoproteinemic plasma.
    Kostner GM
    Ric Clin Lab; 1982; 12(1):155-61. PubMed ID: 6806883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.